Community Update: Ochsner Vaccine Trial
Ochsner was selected as 1 of 73 sites around the world to test Pfizer’s COVID-19 vaccine. In total, Pfizer has received over $1B in funding from BARDA – a testament to their ability to develop a safe and effective vaccine that can meet the urgent needs of our nation. This is just one exemplary component of the massive effort to develop a COVID-19 vaccine, and there is surely no shortage of questions about this overall process. The study officials at Ochsner are happy to answer your questions. Simply contact them at 504-703-8283 or email COVIDvaccine@ochsner.org to learn more. You can learn more about this recent development here.